•The temporal trends of incidence, prevalence, mortality, and disability-adjusted life years of inflammatory bowel disease in the Chinese population aged 0-54â¯years and prediction to 2030
•Gut microbial metabolites in inflammatory bowel disease: immunological mechanisms regulating Treg/Th17 balance and therapeutic potential
•The IBD-disk accurately assesses disability and psychological burden at IBD diagnosis and predicts adverse outcomes in both UC and Crohn's disease during the first year of treatment: a prospective observational cohort study
•Curcumin-QingDai combination for patients with active Crohn's disease: a retrospective, real-world multicenter cohort study
•Alterations in serum and intestinal ACE2 in Inflammatory Bowel Disease and the impact of inflammation
